List of works - Catherine Carmichael

A pedigree with autosomal dominant thrombocytopenia, red cell macrocytosis, and an occurrence of t(12:21) positive pre-B acute lymphoblastic leukemia.

scientific article

ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia.

scientific article published in March 2017

Genomic subtyping and therapeutic targeting of acute erythroleukemia

scientific article published on 29 March 2019

Hematopoietic defects in the Ts1Cje mouse model of Down syndrome

scientific article published on 24 December 2008

Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia.

scientific article

Low-Fouling and Biodegradable Protein-Based Particles for Thrombus Imaging

article

Mouse models of diseases of megakaryocyte and platelet homeostasis.

scientific article published on 11 June 2011

Multiplex ligation-dependent probe amplification (MLPA) genotyping assay for mouse models of down syndrome

scientific article published on 01 May 2007

Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome

scientific article published on 15 October 2009

Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia

scientific article published on 9 January 2017

Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes

scientific article published on 29 April 2010

RUNX1 mutations are rare in chronic phase polycythaemia vera.

scientific article

Setdb1-mediated H3K9 methylation is enriched on the inactive X and plays a role in its epigenetic silencing

scientific article published on 18 May 2016

The Snail Family in Normal and Malignant Haematopoiesis.

scientific article published on 20 February 2017

Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome

scientific article published on 09 December 2009

Variability of inducible expression across the hematopoietic system of tetracycline transactivator transgenic mice.

scientific article

ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling.

scientific article

List of works by Catherine Carmichael

A pedigree with autosomal dominant thrombocytopenia, red cell macrocytosis, and an occurrence of t(12:21) positive pre-B acute lymphoblastic leukemia.

ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia.

Genomic subtyping and therapeutic targeting of acute erythroleukemia

Hematopoietic defects in the Ts1Cje mouse model of Down syndrome

Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia.

Low-Fouling and Biodegradable Protein-Based Particles for Thrombus Imaging

Mouse models of diseases of megakaryocyte and platelet homeostasis.

Multiplex ligation-dependent probe amplification (MLPA) genotyping assay for mouse models of down syndrome

Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome

Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia

Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes

RUNX1 mutations are rare in chronic phase polycythaemia vera.

Setdb1-mediated H3K9 methylation is enriched on the inactive X and plays a role in its epigenetic silencing

The Snail Family in Normal and Malignant Haematopoiesis.

Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome

Variability of inducible expression across the hematopoietic system of tetracycline transactivator transgenic mice.

ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling.